Davis Capital Management
COLL icon

Davis Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Davis Capital Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-2
Closed -$72 – 1216
2026
Q2 		$72 Buy
+2
New +$68 ﹤0.01% 1141

Other funds holding COLL

Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Ballast Asset Management
Ballast Asset Management Dallas, Texas $230M AUM 34.36% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Davis Capital Management's COLL Position: Q3 2026 in Review

Davis Capital Management sold out of Collegium Pharmaceutical (COLL) in Q3 2026, closing a stake of 2 shares — an estimated $72 sold.

Davis Capital Management first reported a position in COLL in Q2 2026 and held it in 1 quarter. The position peaked at $72 in Q2 2026. 77 funds tracked by Wall St. Rank hold COLL as of Q3 2026.

  • Davis Capital Management reported no remaining Collegium Pharmaceutical position as of Q3 2026 after selling out during the quarter.
  • Davis Capital Management sold 2 Collegium Pharmaceutical shares in Q3 2026, an estimated $72.
  • Davis Capital Management first reported a position in Collegium Pharmaceutical in Q2 2026 and held it in 1 quarter.
  • Davis Capital Management's Collegium Pharmaceutical position peaked at $72 in Q2 2026.
  • 77 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.

Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.